Hyperion DeFi (NASDAQ:HYPD) Upgraded by Zacks Research to “Hold” Rating

Posted by on Sep 12th, 2026

Hyperion DeFi (NASDAQ:HYPD – Get Free Report) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Thursday, Zacks reports.

Other equities analysts have also issued research reports about the company. Weiss Ratings raised Hyperion DeFi from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, September 1st. Cantor Fitzgerald reissued an “overweight” rating and set a $11.20 price target (up from $7.10) on shares of Hyperion DeFi in a research report on Thursday. Finally, Chardan Capital upped their price objective on Hyperion DeFi from $7.30 to $8.45 and gave the company a “buy” rating in a research report on Tuesday. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $9.82.

Check Out Our Latest Research Report on HYPD

Hyperion DeFi Price Performance

Shares of NASDAQ HYPD opened at $3.49 on Thursday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.34 and a current ratio of 2.34. The company has a market capitalization of $54.23 million, a price-to-earnings ratio of -0.53 and a beta of 2.53. The company has a 50 day simple moving average of $2.97 and a two-hundred day simple moving average of $3.29. Hyperion DeFi has a fifty-two week low of $2.34 and a fifty-two week high of $15.00.

Hyperion DeFi (NASDAQ:HYPD – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.92 earnings per share for the quarter. Hyperion DeFi had a negative return on equity of 11.62% and a net margin of 416.56%.The company had revenue of $0.36 million during the quarter. Analysts expect that Hyperion DeFi will post 1.78 EPS for the current fiscal year.

Institutional Trading of Hyperion DeFi

Several large investors have recently modified their holdings of HYPD. Price T Rowe Associates Inc. MD purchased a new stake in Hyperion DeFi during the fourth quarter valued at $73,000. State Street Corp bought a new stake in shares of Hyperion DeFi during the 4th quarter valued at about $92,000. Investment House LLC bought a new stake in shares of Hyperion DeFi during the 4th quarter valued at about $166,000. Geode Capital Management LLC purchased a new stake in shares of Hyperion DeFi during the 4th quarter valued at about $214,000. Finally, Focus Partners Advisor Solutions LLC purchased a new stake in shares of Hyperion DeFi during the 4th quarter valued at about $221,000. Institutional investors own 25.84% of the company’s stock.

About Hyperion DeFi

(Get Free Report)

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.

Featured Stories

Receive News & Ratings for Hyperion DeFi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperion DeFi and related companies with MarketBeat.com's FREE daily email newsletter.